Act fast! Until October 31st, the Food and Drug Administration is accepting public comments on how the United States classifies cannabis under international drug treaties. The White House and the FDA may take your comments into consideration when discussing drug policy at the World Health Organization meeting next month in Geneva, Switzerland.
Is all this confusing? Probably, however, there are a few reasons why you should care. Firstly, this is one of the few times you can directly register official comments on anything related to cannabis with the federal government. Secondly, there are many, many reasons why cannabis isn’t legal in the United States. International agreements related to cannabis are a major stumbling block. The World Health Organization considers cannabis a Schedule I drug, which (just like in the United States) classifies it as the most restrictive drug. Perhaps de-scheduling cannabis (especially amid a domestic and global fentanyl crisis) can be on the table if the US desires such action to take place.
As Leafly points out, the FDA still considers CBD to be a Schedule I drug despite the agency’s own findings solely because of international drug treaties. These treaties matter and there is potential for the United States to reconsider these treaties based on public comments.
Accountability and participation in governance is a good thing. Regardless of your political ideology, you should take any and all opportunities to have your opinions known. Democracies function their best when people participate! Afterward, celebrate with a little green! The freedom to petition the government rules! Speak up and toke on Dreamers!
Here is the link, again, in case you missed it: Click Here To Submit Comments.